Skip to content

Clinical Study on Tongrushuluo Decoction and Massage Therapy for Breast Carbuncle based on the Abnormal Collaterals Theory

Clinical Study on Tongrushuluo Decoction and Massage Therapy for Breast Carbuncle based on the Abnormal Collaterals Theory

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-14005372
Enrollment
Unknown
Registered
2014-09-29
Start date
2013-11-19
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lactational mastitis

Interventions

treatment group:Tongrushuluo decoction combined with massage treatment
control group 1:Tongrushuluo decoction treatment
control group 2:massage treatment

Sponsors

Dongfang Hospital Affiliated to Beijing University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. In accordance with the diagnosis criteria of acute mastitis; 2. In accordance with the diagnosis criteria of stasis period; 3. In accordance with the diagnosis of breast carbuncle and TCM syndrome differentiation for qi stagnation and heat obstruction; 4. Lactating women; 5. Aged between 18 and 50 years old; 6.Voluntary and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant woman, patients with inverted nipple; 2. Patients with breast abscess formation; 3. Patients combined malignant or benign breast tumor; 4. Patients combined serious diseases of heart, liver, kidney, hematopoietic system or psychiatric illness; 5. Patients allergic to drugs.

Design outcomes

Primary

MeasureTime frame
Breast pain;Breast mass size;

Secondary

MeasureTime frame
T;Breast milk excretion;Scope of skin redness;WBC count;Neutrophil count;

Countries

China

Contacts

Public ContactTaohua Li
taohuali@126.com+86 13522056682

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026